Literature DB >> 12230556

Isoprenoid biosynthesis via the methylerythritol phosphate pathway. Mechanistic investigations of the 1-deoxy-D-xylulose 5-phosphate reductoisomerase.

Jean-François Hoeffler1, Denis Tritsch, Catherine Grosdemange-Billiard, Michel Rohmer.   

Abstract

The 1-deoxyxylulose 5-phosphate reductoisomerase (DXR, EC 1.1.1.267) catalyzes the conversion of 1-deoxy-d-xylulose 5-phosphate (DXP) into 2-C-methyl-d-erythritol 4-phosphate (MEP). This transformation is a two-step process involving a rearrangement of DXP into the putative intermediate 2-C-methyl-d-erythrose 4-phosphate followed by a NADPH-dependent reduction of the latter aldehyde. By using [1-(13)C]DXP as a substrate, the rearrangement of DXP into [5-(13)C]2-C-methyl-d-erythrose 4-phosphate was shown to be NADPH dependent, although it does not involve areduction step. The putative aldehyde intermediate, obtained by chemical synthesis, was converted into MEP by the DXR in the presence of NADPH and into DXP in the presence of NADP(+), indicating the reversibility of the reaction catalyzed by the DXR. This reversibility was confirmed by the conversion of MEP into DXP in the presence of NADP(+). The equilibrium was, however, largely displaced in favour of the formation of MEP. The reduction step required the presence of a divalent cation such as Mg(2+) or Mn(2+).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230556     DOI: 10.1046/j.1432-1033.2002.03150.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

1.  Terpene Specialized Metabolism in Arabidopsis thaliana.

Authors:  Dorothea Tholl; Sungbeom Lee
Journal:  Arabidopsis Book       Date:  2011-04-06

Review 2.  The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.

Authors:  Hyungjin Eoh; Patrick J Brennan; Dean C Crick
Journal:  Tuberculosis (Edinb)       Date:  2008-09-14       Impact factor: 3.131

3.  Noncovalent Intermediate of Thymidylate Synthase: Fact or Fiction?

Authors:  Svetlana A Kholodar; Amnon Kohen
Journal:  J Am Chem Soc       Date:  2016-06-24       Impact factor: 15.419

4.  Inhibition Studies on Enzymes Involved in Isoprenoid Biosynthesis: Focus on Two Potential Drug Targets: DXR and IDI-2 Enzymes.

Authors:  Jérôme de Ruyck; Johan Wouters; C Dale Poulter
Journal:  Curr Enzym Inhib       Date:  2011-07

Review 5.  Biochemistry of the non-mevalonate isoprenoid pathway.

Authors:  Tobias Gräwert; Michael Groll; Felix Rohdich; Adelbert Bacher; Wolfgang Eisenreich
Journal:  Cell Mol Life Sci       Date:  2011-07-09       Impact factor: 9.261

Review 6.  Methylerythritol phosphate pathway of isoprenoid biosynthesis.

Authors:  Lishan Zhao; Wei-chen Chang; Youli Xiao; Hung-wen Liu; Pinghua Liu
Journal:  Annu Rev Biochem       Date:  2013       Impact factor: 23.643

7.  Simulation of a Petri net-based model of the terpenoid biosynthesis pathway.

Authors:  Aliah Hazmah Hawari; Zeti-Azura Mohamed-Hussein
Journal:  BMC Bioinformatics       Date:  2010-02-09       Impact factor: 3.169

8.  Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase.

Authors:  Lionel Kuntz; Denis Tritsch; Catherine Grosdemange-Billiard; Andréa Hemmerlin; Audrey Willem; Thomas J Bach; Michel Rohmer
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

Review 9.  From molecular fossils of bacterial hopanoids to the formation of isoprene units: discovery and elucidation of the methylerythritol phosphate pathway.

Authors:  Michel Rohmer
Journal:  Lipids       Date:  2008-11-15       Impact factor: 1.880

10.  A secondary kinetic isotope effect study of the 1-deoxy-D-xylulose-5-phosphate reductoisomerase-catalyzed reaction: evidence for a retroaldol-aldol rearrangement.

Authors:  Jeffrey W Munos; Xiaotao Pu; Steven O Mansoorabadi; Hak Joong Kim; Hung-wen Liu
Journal:  J Am Chem Soc       Date:  2009-02-18       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.